Keyword: Zealand Pharma

News

Novo Nordisk Licenses Zealand’s Diabetes Treatment

09.09.2022 -

Denmark’s Novo Nordisk has entered into a global license and development with compatriot biotech Zealand Pharma for the latter’s Zegalogue (dasiglucagon) injectable...

News

Sanofi Aims to Expand in Diabetes Market

01.06.2012 - Sanofi aims to build on its diabetes portfolio, which has so far relied on blockbuster insulin Lantus, with a wider range of treatments that could address not just the disease but...